Philip S Low

No ORCID on file · 4 papers in corpus
other 2018
Oncotarget ·doi:10.18632/oncotarget.23155

OBJECTIVE: Detection and resection of all malignant lesions is pivotal in staging and cytoreductive surgery (CRS) of endometrial cancer (EC). Intraoperative EC detection could be enhanced using OTL-38, a fluorescent-labelled folate receptor…

other 2015
PloS one ·doi:10.1371/journal.pone.0135012

AIMS: Tumor-specific targeted imaging is rapidly evolving in cancer diagnosis. The folate receptor alpha (FR-α) has already been identified as a suitable target for cancer therapy and imaging. FR-α is present on ~40% of human cancers. FR-β …

other 2009
PloS one ·doi:10.1371/journal.pone.0006292

BACKGROUND: Despite low incidence, ovarian cancer is the fifth leading cause of cancer deaths and it has the highest mortality rate of all gynecologic malignancies among US women. The mortality rate would be reduced with an early detection …

other 2008
International journal of cancer ·doi:10.1002/ijc.23717

Quantitation of circulating tumor cells (CTCs) can provide information on the stage of a malignancy, onset of disease progression and response to therapy. In an effort to more accurately quantitate CTCs, we have synthesized fluorescent conj…